Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 2/20 | 0.38 |
| ▸ | IGF1R | P08069 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.35 |
| ▸ | MLNR | O43193 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15960474 | 1.00 | GRIN2B (0.38) | GRIN2BIGF1RALOX15SIGMAR1S1PR1 | |
| SCHEMBL19668939 | 1.00 | GRIN2B (0.38) | GRIN2BIGF1RALOX15SIGMAR1S1PR1 | |
| SCHEMBL16682944 | 0.84 | ALDH1A1 (0.42) | GRIN2BALOX15MLNRDRD2 | |
| SCHEMBL19996369 | 0.81 | SLC6A2 (0.50) | S1PR1MLNRDRD2SLC6A2HTR2A | |
| SCHEMBL27391726 | 0.81 | GRIN2B (0.38) | GRIN2BIGF1RALOX15S1PR1MLNR | |
| SCHEMBL16682975 | 0.81 | GRIN2B (0.38) | GRIN2BIGF1RALOX15S1PR1MLNR | |
| SCHEMBL12588032 | 0.81 | GRIN2B (0.38) | GRIN2BIGF1RALOX15S1PR1MLNR | |
| SCHEMBL12379609 | 0.81 | GRIN2B (0.38) | GRIN2BIGF1RALOX15S1PR1MLNR | |
| SCHEMBL9711010 | 0.79 | DRD2 (0.39) | GRIN2BMLNRDRD2 | |
| SCHEMBL10169204 | 0.78 | GRIN2B (0.38) | GRIN2BIGF1RALOX15MLNRDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9929347-B2 | Polymer compound and light emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) | 2018-03-27 | — | — | US | disclosed |
| US-9929347-B2 | Polymer compound and light emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) | 2018-03-27 | — | — | US | disclosed |
| US-20150115204-A1 | POLYMER COMPOUND AND LIGHT EMITTING ELEMENT USING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-04-30 | — | — | US | disclosed |
| US-20150115204-A1 | POLYMER COMPOUND AND LIGHT EMITTING ELEMENT USING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150115204-A1 | POLYMER COMPOUND AND LIGHT EMITTING ELEMENT USING SAME | NAP1L4, AHR, NR0B1 | GRIN2B 2099/4885IGF1R 541/4885ALOX15 856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.